Another recent approach using a compound drug consisting of an aptamer targeting PDGFbeta and an siRNA targeting Stat3 in glioma showed similar growth retardation in vitro and in vivo [19], although this study only used subcutaneous xenografts for the in vivo experiments. The gene discussed is STAT3; the disease is glioma.